Gentamicin Dosing for Non-Dialysis Patients
For patients not on dialysis with normal renal function, administer gentamicin 3 mg/kg/day divided into three equal doses every 8 hours for serious infections, or 5 mg/kg/day in three or four divided doses for life-threatening infections (reduced to 3 mg/kg/day as soon as clinically indicated). 1
Dosing Based on Renal Function
The FDA-approved dosing strategy requires adjustment based on creatinine clearance (CrCl):
Normal Renal Function (CrCl >100 mL/min)
- Standard serious infections: 3 mg/kg/day divided every 8 hours
- Life-threatening infections: Up to 5 mg/kg/day divided every 6-8 hours initially, then reduce to 3 mg/kg/day 1
- Calculate dose based on lean body weight in obese patients 1
Impaired Renal Function (Not on Dialysis)
The dosing interval must be extended based on serum creatinine. A practical approach: multiply the serum creatinine (mg/dL) by 8 to determine the interval in hours 1. For example:
- Serum creatinine 2.0 mg/dL → dose every 16 hours (2 × 8)
- Serum creatinine 3.0 mg/dL → dose every 24 hours (3 × 8)
Alternatively, reduce the dose while maintaining 8-hour intervals by dividing the normal dose by the serum creatinine level 1.
Specific Clinical Context Dosing
Endocarditis (Prosthetic Valve)
- 3 mg/kg/day divided into 2-3 equal doses for the initial 2 weeks only when combined with beta-lactams or vancomycin 2
- This is a Class I, Level B recommendation
Critically Ill/Septic Patients
Recent evidence suggests higher initial dosing may be needed:
- 7 mg/kg once daily for hyperdynamic septic patients with normal renal function 3
- Volume of distribution is significantly increased in sepsis, requiring higher loading doses 3
- Once-daily dosing is feasible and preferred in ICU settings 4, 3
Multiple Trauma Patients
- 6-7 mg/kg once daily for infection prevention when MIC <1 mg/L 5
- Higher doses up to 10 mg/kg/day cannot achieve treatment targets for serious infections when MIC ≥1 mg/L 5
Therapeutic Drug Monitoring Requirements
Measure both peak and trough levels when therapy extends beyond 48 hours 1:
Target Levels
- Peak (30-60 min post-IM injection): 4-6 mcg/mL for standard dosing
- Trough (just before next dose): <2 mcg/mL to avoid nephrotoxicity 1
- Avoid prolonged levels >12 mcg/mL 1
Extended Interval Dosing Targets
For once-daily dosing:
- Peak (Cmax): >10 mg/L 6
- Trough at 24 hours: <0.5 mg/L 6
- AUC24h/MIC: ≥110 for treatment, ≥50 for prevention 4, 5
Adjusting Intervals for Renal Impairment
Use these initial dose intervals based on CrCl 6:
- CrCl ≥60 mL/min → 24-hour intervals
- CrCl 40-59 mL/min → 36-hour intervals
- CrCl 20-39 mL/min → 48-hour intervals
This approach achieves target peak concentrations in 94-98% of patients while maintaining safe trough levels 6.
Critical Safety Considerations
Nephrotoxicity Risk
- Occurs in approximately 4% of patients, with irreversible damage in 1% overall 6
- Risk increases with:
Duration of Therapy
- Limit treatment to 7-10 days for most infections 1
- 3-5 days maximum in critically ill patients due to poor tissue penetration 3
- Monitor renal, auditory, and vestibular function if treatment exceeds 10 days 1
Common Pitfalls to Avoid
- Don't use actual body weight in obese patients - always calculate based on lean body mass 1
- Don't assume stable renal function - deteriorating kidney function requires greater dose reduction than initial calculations suggest 1
- Don't use gentamicin monotherapy for serious infections when MIC ≥2 mg/L - it cannot achieve therapeutic targets even at maximum doses 4, 5
- Don't skip TDM in burn patients or those with altered pharmacokinetics - they often have reduced serum concentrations requiring dose adjustment 1